Median age (upper quartile, lower quartile) | 7.5Â years (5.5, 9) |
---|---|
Symptoms | |
 Nasal discharge | 57 (72%) |
 Sneezing | 83 (93%) |
 Nasal obstruction | 70 (78%) |
 Nasal itching | 56 (63%) |
Watery itchy eyes | |
Diagnosis: aeroallergen sensitisation | |
 SPT done | 68 (76%) |
 1 or more positive SPT | 60 (88%) |
 Specific IgE done | 45 (50%) |
 SPT or specific IgE done | 76 (85%) |
Classification of AR | |
Intermittent | 29 (33%) |
 Mild | 20 (69%) |
 Moderate-severe | 9 (31%) |
Persistent | 60 (67%) |
 Mild | 28 (47%) |
 Moderate-severe | 32 (53%) |
Asthma management (GINA stage) | |
 Stage 1 | 3 (4%) |
 Stage 2 | 24 (27%) |
 Stage 3 | 43 (48%) |
 Stage 4/5 | 18 (20%) |
Leukotriene receptor antagonist | 65 (73%) |
AR treatment | |
 No treatment | 20 (23%) |
 Intermittent treatment | 55 (61%) |
 Regular treatment | 14 (16%) |